Paternity Testing While Pregnant: What's Possible in India

• Prenatal paternity testing exists in three forms: a non-invasive maternal blood test (NIPP), and two invasive procedures (CVS and amniocentesis). Only NIPP carries no miscarriage risk.
• In India, prenatal paternity testing is rarely performed. The PCPNDT Act tightly restricts what prenatal DNA testing can be used for, samples often have to be sent abroad, and the cost can run to several lakh rupees.
• Postnatal DNA paternity testing is the Indian standard: it costs roughly INR 8,000-25,000, is over 99.9% accurate, painless, and accepted as legal evidence when done with proper documentation.
• Every reputable DNA test needs consent from the people being tested. Secretly collecting a sample from the alleged father raises legal and ethical problems and may not hold up in court.
• Paternity questions in pregnancy carry real emotional weight. Confidential counselling and support are available, and your obstetrician's role is to inform, not to judge.

A paternity test compares the child's DNA with the DNA of one or more possible fathers. We all inherit half our DNA from our biological mother and half from our biological father, so a true father's DNA will match the child at every tested marker. If enough markers do not match, paternity is excluded.

Standard testing looks at about 15-25 short tandem repeat (STR) markers and gives a very confident answer: usually above 99.9% probability when a man is the father, and essentially 0% when he is not. After birth the test is simple, just a cheek swab from the baby and the man. The real challenge is doing it during pregnancy, because the baby's DNA is not easy to reach safely. That is what the next sections are about.

• The law is restrictive. The Pre-conception and Pre-natal Diagnostic Techniques (PCPNDT) Act, 1994 was created mainly to stop illegal prenatal sex determination. It allows prenatal DNA testing only for specific medical reasons such as chromosomal abnormalities, genetic disorders, and congenital conditions. Paternity is not on that list, which leaves voluntary prenatal paternity testing in a legally grey area that most Indian doctors and labs avoid.
• It is expensive. Because few Indian labs are accredited for NIPP, samples usually have to be shipped to laboratories abroad. With shipping, processing, and reporting, the total can reach roughly INR 1,00,000-3,00,000.
• Postnatal testing is far cheaper and just as accurate. A DNA test after birth costs about INR 8,000-25,000 and gives the same answer, so the prenatal expense is hard to justify for most families.
• Limited lab infrastructure. Indian molecular labs have grown rapidly for NIPT, but most have not extended into paternity testing because demand is small and the regulatory ground is uncertain.
• Cultural and practical sensitivity. Raising a paternity question during pregnancy can have serious family and social consequences, and the test needs the alleged father's cooperation and DNA, which means the question cannot stay private.

If you are weighing NIPP through an international service, it helps to understand the mechanics.

The biology. The placenta constantly renews itself, releasing short fragments of fetal DNA into your blood. Early on, around 7-8 weeks, the baby's DNA makes up only about 5-10% of the cell-free DNA in your plasma (the "fetal fraction"), rising to 10-20% or more by mid-pregnancy. A higher fetal fraction gives a more reliable result, which is why testing too early can occasionally fail and need repeating.

What is collected. A venous blood sample from you (about 10-20 mL) and a DNA sample from the alleged father (usually a cheek swab). If the result might be used legally, both samples must be collected with a documented chain of custody.

In the lab. The cell-free DNA is sequenced, the baby's DNA is separated from yours based on inheritance patterns, and thousands of genetic markers (SNPs) are compared with the father's DNA to calculate a probability of paternity. Results, usually in 1-3 weeks, report a probability approaching 99.9% for a match or near 0% for an exclusion.

When results may be unclear. The most common reason is too little fetal DNA, fixed by retesting a little later. Less commonly, poor sample quality, certain twin pregnancies, a recent blood transfusion or organ transplant, or some maternal illnesses can interfere.

Accreditation matters. Trustworthy NIPP comes from AABB-accredited (or equivalent) laboratories with validated methods and proper quality control. Be wary of marketing-led services without rigorous accreditation.

Both CVS and amniocentesis can give paternity results equal in accuracy to a postnatal test, because they sample the baby's own cells directly. But they exist to diagnose genetic and chromosomal conditions, not to answer paternity questions, and they carry a small but real miscarriage risk.

CVS, between 10-13 weeks, takes 5-20 mg of placental villi. Amniocentesis, from 15 weeks, draws 15-30 mL of amniotic fluid. Both are done under ultrasound guidance by experienced fetal-medicine specialists. Both carry roughly a 0.5-1% procedure-related miscarriage risk (lower in high-volume centres), with rare risks of infection, bleeding, or fluid leak. If you are Rh-negative, you will be given anti-D immunoglobulin afterwards to prevent sensitisation.

These procedures are usually performed when there is a genuine clinical reason, such as a high-risk screening result or carrier status for an inherited condition like thalassemia or sickle cell. Choosing an invasive procedure solely for paternity means accepting a real pregnancy-loss risk for a question that postnatal testing answers safely, which is why it is essentially never done this way in routine Indian practice.

For most families, the simplest and best path is to wait until after birth.

The sample is just a painless cheek swab from the baby and the alleged father (cord blood collected at delivery also works). Swabs stay stable for weeks at room temperature, so there is no rush. A lab compares 15-25 STR markers and reports a probability of paternity, typically over 99.99% when a man is the father, and essentially 0% when he is not. Accredited testing is over 99.9% accurate; genuine errors are almost always sample mix-ups, not technical failures.

In India, postnatal paternity testing costs about INR 8,000-25,000, and is offered by NABL-accredited DNA laboratories and major hospital chains across metro cities. For legal use, the test must be done with verified identity and a documented chain of custody; a cheaper "peace-of-mind" test uses the same technology but is not admissible in court. As with any DNA testing, think carefully about who holds your genetic data and how it is protected.

Paternity questions in pregnancy rarely arrive in a calm moment. They can follow a relationship change, uncertain timing of conception, infidelity, or, painfully, sexual assault. Whatever the circumstance, your feelings are valid, and you do not have to navigate them alone.

Confidential counselling lets you explore your options without immediate consequences. Indian mental-health platforms such as Wysa, YourDost, Amaha, and Lissun offer accessible support, and hospital psychiatry and obstetric counsellors can step in when more help is needed. Decisions about disclosure, to a current partner, to family, to the child in time, involve real trade-offs and are deeply personal; prenatal genetic counselling services and family therapy can help you think them through.

If you are facing this question after sexual assault, your safety and healing come first, not paternity. Survivor-care services in India, the women's helpline (181), and OneStop Centres can support both the medical and legal sides. The MTP framework specifically allows later termination for survivors of assault, which we cover under abortion rights in India.

Throughout, your obstetrician's role is to give you accurate information and referrals, not to push you toward or away from testing. The decision is yours, and your conversations are confidential.

A few legal points are worth knowing at a high level.

The PCPNDT Act restricts prenatal DNA testing to specific medical indications, which is the main reason prenatal paternity testing is not routinely offered. Postnatal DNA evidence, by contrast, is well established and accepted in Indian courts for maintenance, succession, and matrimonial cases when properly documented.

Timing can matter. Under the MTP Act (amended 2021), termination is permitted on the woman's request up to 20 weeks, and up to 24 weeks for specific categories including survivors of assault and women whose marital status changes during pregnancy. NIPP results can in principle arrive before these thresholds, which is one reason some women abroad choose prenatal testing; if this is relevant to you, our guide to the medical termination process and its timelines explains the steps.

Consent is non-negotiable. Every reputable DNA test requires the informed consent of those being tested. Collecting a father's sample secretly is legally and ethically fraught and may be inadmissible. For legal weight, use NABL-accredited laboratories with proper chain-of-custody documentation. Free or subsidised legal help is available through State and District Legal Services Authorities and women's commissions.

• You are weighing a paternity question and want to understand your safe, accurate options without judgment.
• You are considering an invasive procedure (CVS or amniocentesis) for any reason and want to understand the miscarriage risk and recovery.
• Your decision about continuing the pregnancy may depend on the result, so timing relative to MTP limits matters.
• The pregnancy follows assault, and you need coordinated medical, emotional, and legal support.
• You are being pressured into surreptitious testing, or you are unsure about consent and your legal rights.

• American College of Obstetricians and Gynecologists (ACOG): Prenatal Genetic Diagnostic Tests (CVS and amniocentesis)
• PCPNDT Act, 1994 (with amendments), Ministry of Health and Family Welfare, Government of India
• Medical Termination of Pregnancy (Amendment) Act, 2021, Government of India
• Indian Council of Medical Research (ICMR): Ethical Guidelines for Biomedical Research and DNA testing
• NHS: Amniocentesis and Chorionic villus sampling (CVS)
• Centre for DNA Fingerprinting and Diagnostics (CDFD), Hyderabad